Glucose homeostasis is maintained through coordinated regulation of glycolysis, gluconeogenesis, and glycogen metabolism. In the fed state, excess glucose is stored as glycogen in liver and muscle or converted to fatty acids for long-term energy storage. In the fasted state, the liver mobilizes glucose via glycogenolysis and gluconeogenesis to maintain blood glucose for glucose-dependent tissues, while other tissues shift to fatty acid oxidation.
Trace glucose flux through glycolysis and glycogenesis in the fed state, then track glucose mobilization from glycogen breakdown and gluconeogenesis in the fasted state. Use metabolic maps to understand how hormonal signals (insulin, glucagon, epinephrine) coordinate these opposing pathways.
You know the individual pathways from your prerequisites — glycolysis breaks glucose to pyruvate, gluconeogenesis reverses this to synthesize glucose, and glycogen metabolism stores and releases glucose polymers. What this topic adds is the systems-level integration: how these pathways are coordinated by hormonal signals in response to the fed-fasted transition, and how different tissues play different roles in maintaining glucose homeostasis. Think of the body not as a single metabolic unit but as a federation of organs with specialized roles, communicating through hormones and metabolite concentrations.
After a meal, blood glucose rises and insulin is secreted from the pancreatic beta cells. Insulin acts as the master signal of nutrient abundance. In the liver, insulin activates glycogen synthase (promoting glycogen storage) and suppresses gluconeogenesis. In muscle, insulin drives GLUT4 translocation to the membrane, enabling glucose uptake for glycolysis and glycogen synthesis. In adipose tissue, insulin promotes glucose uptake and inhibits lipolysis. The combined effect is rapid clearance of postprandial glucose from the blood — roughly 100–150 g of glucose can be stored as glycogen across liver and muscle, and excess beyond that is converted to fatty acids via *de novo* lipogenesis. Notice that the liver is both a major glucose consumer and the primary site of glucose production — its metabolic direction flips entirely depending on the hormonal environment.
During fasting, blood glucose falls, insulin drops, and glucagon rises (secreted by pancreatic alpha cells). Glucagon acts primarily on the liver — it activates glycogen phosphorylase (releasing glucose from glycogen) and upregulates gluconeogenic enzymes. The liver begins manufacturing glucose from lactate, amino acids, and glycerol, and exporting it into the blood. Skeletal muscle, interestingly, *cannot* export glucose from glycogenolysis directly because it lacks glucose-6-phosphatase — muscle glycogen serves the muscle itself, not blood glucose homeostasis. The liver's unique possession of glucose-6-phosphatase makes it the guardian of blood glucose during fasting.
Fuel selection across tissues is governed by the interplay of glucose availability, hormonal signals, and each tissue's metabolic priorities. The brain is almost entirely glucose-dependent under normal conditions — it cannot oxidize fatty acids (which do not cross the blood-brain barrier in significant quantity) and has no glycogen stores to speak of. Maintaining blood glucose above ~4 mM is thus a survival priority, which explains why the glucagon-gluconeogenesis axis is so robustly defended. Red blood cells are obligate glucose consumers because they lack mitochondria and cannot perform oxidative phosphorylation. Muscle uses glucose during high-intensity exercise (where glycolysis outpaces oxidative capacity) but shifts to fatty acid oxidation during sustained moderate-intensity activity. The liver is metabolically unique — it can use whatever fuel is available, shift between anabolic and catabolic modes under hormonal control, and synthesize ketone bodies during prolonged fasting as an alternative fuel for the brain.
Prolonged fasting — beyond 24 hours — depletes liver glycogen and forces the body into an adaptive state. Ketogenesis ramps up as fatty acid oxidation in the liver exceeds the TCA cycle's capacity to process acetyl-CoA; the overflow is condensed into ketone bodies (acetoacetate, β-hydroxybutyrate) that are exported and used by the brain, heart, and muscle. Over days of fasting, the brain progressively adapts to running on ketones, reducing its glucose demand and sparing amino acid catabolism that would otherwise supply gluconeogenesis. This metabolic flexibility — the capacity to shift fuel sources in response to availability — is a defining feature of human metabolism and underpins both the physiology of fasting and the therapeutic rationale for ketogenic diets.